Literature DB >> 284330

Sterigmatocystin-DNA interactions: identification of a major adduct formed after metabolic activation in vitro.

J M Essigmann, L J Barker, K W Fowler, M A Francisco, V N Reinhold, G N Wogan.   

Abstract

Sterigmatocystin (ST), a potent hepatocarcinogen, was covalently bound to calf thymus DNA by incubation in the presence of phenobarbital-induced rat liver microsomes. Acid hydrolysis of ST-modified DNA liberated a major guanine-containing adduct, present in DNA at an estimated level of 1 ST residue per 100-150 nucleotides. The adduct was isolated by high-pressure liquid chromatography and subjected to structural analysis. Spectral and chemical data identified the adduct as 1,2-dihydro-2-(N(7)-guanyl)-1-hydroxysterigmatocystin, the guanine and hydroxyl moieties being in a trans configuration. The structure and stereochemistry of this adduct indicated that the exo-ST-1,2-oxide was the metabolite that reacted with DNA, and the quantitative yield of adduct indicated that this metabolite was a major product of the in vitro metabolism of ST.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 284330      PMCID: PMC382900          DOI: 10.1073/pnas.76.1.179

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo.

Authors:  J K Lin; J A Miller; E C Miller
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

2.  Quantitative determination of transfer RNA base composition using high-pressure liquid chromatography.

Authors:  J M Essigmann; W F Busby; G N Wogan
Journal:  Anal Biochem       Date:  1977-08       Impact factor: 3.365

3.  Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.

Authors:  J M Essigmann; R G Croy; A M Nadzan; W F Busby; V N Reinhold; G Büchi; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

4.  Carcinogen activation by human liver enzymes in the Ames mutagenicity test.

Authors:  T Tang; M A Friedman
Journal:  Mutat Res       Date:  1977-12       Impact factor: 2.433

5.  The toxicity and chemical assay of sterigmatocystin, a carcinogenic mycotoxin, and its isolation from two new fungal sources.

Authors:  C W Holzapfel; I F Purchase; P S Steyn; L Gouws
Journal:  S Afr Med J       Date:  1966-12-17

6.  Tumor induction by a single subcutaneous injection of sterigmatocystin in newborn mice.

Authors:  K Fujii; H Kurata; S Odashima; Y Hatsuda
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

7.  Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae.

Authors:  M H Kuczuk; P M Benson; H Heath; A W Hayes
Journal:  Mutat Res       Date:  1978-02       Impact factor: 2.433

8.  Mutagenicity of fungal metabolites related to aflatoxin biosynthesis.

Authors:  J J Wong; R Singh; D P Hsieh
Journal:  Mutat Res       Date:  1977-09       Impact factor: 2.433

9.  Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.

Authors:  R G Croy; J M Essigmann; V N Reinhold; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

10.  Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.

Authors:  D H Swenson; J K Lin; E C Miller; J A Miller
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

View more
  6 in total

1.  A Comprehensive Database for DNA Adductomics.

Authors:  Giorgia La Barbera; Katrine Dalmo Nommesen; Catalina Cuparencu; Jan Stanstrup; Lars Ove Dragsted
Journal:  Front Chem       Date:  2022-05-27       Impact factor: 5.545

2.  Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.

Authors:  T Shimada; F P Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Sterigmatocystin moderately induces oxidative stress in male Wistar rats after short-term oral treatment.

Authors:  Rašić Dubravka; Jakšić Daniela; Hulina Tomašković Andrea; Kifer Domagoj; Kopjar Nevenka; Rumora Lada; Želježić Davor; Peraica Maja; Šegvić Klarić Maja
Journal:  Mycotoxin Res       Date:  2019-12-13       Impact factor: 3.833

4.  Unique Aggregation of Sterigmatocystin in Water Yields Strong and Specific Circular Dichroism Response Allowing Highly Sensitive and Selective Monitoring of Bio-Relevant Interactions.

Authors:  Daniela Jakšić; Maja Šegvić Klarić; Ivo Crnolatac; Nataša Šijaković Vujičić; Vilko Smrečki; Marcin Górecki; Gennaro Pescitelli; Ivo Piantanida
Journal:  Mar Drugs       Date:  2019-11-06       Impact factor: 5.118

5.  Comparison Evaluation of the Biological Effects of Sterigmatocystin and Aflatoxin B1 Utilizing SOS-Chromotest and a Novel Zebrafish (Danio rerio) Embryo Microinjection Method.

Authors:  Zsolt Csenki; Anita Risa; Dorottya Sárkány; Edina Garai; Ildikó Bata-Vidács; Erzsébet Baka; András Szekeres; Mónika Varga; András Ács; Jeffrey Griffitts; Katalin Bakos; Illés Bock; István Szabó; Balázs Kriszt; Béla Urbányi; József Kukolya
Journal:  Toxins (Basel)       Date:  2022-03-31       Impact factor: 5.075

6.  Proapoptotic activity of aflatoxin B1 and sterigmatocystin in HepG2 cells.

Authors:  Yang Liu; Ming Du; Genyi Zhang
Journal:  Toxicol Rep       Date:  2014-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.